Nitrooxy derivatives as angiotensin II receptor antagonists

Details for Australian Patent Application No. 2009322613 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Ali, Amjad; Lo, Michael Man-Chu; Nargund, Ravi P.

Agent Spruson & Ferguson

Pub. Number AU-A-2009322613

PCT Pub. Number WO2010/065432

Priority 61/200,964 05.12.08 US

Filing date 30 November 2009

Wipo publication date 10 June 2010

International Classifications

C07D 235/08 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065432 Priority application(s): WO2010/065432

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322616-System and method for mechanical closure of wounds

2009322607-Methods and compositions for detection of complement fixing antibodies